News and Events Filter All Events Press Releases October 12, 2020Immunomedics Announces FDA Orphan Drug Designation of Trodelvyᵀᴹ for Glioblastoma September 19, 2020Immunomedics ESMO 2020 Update Call September 19, 2020Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvyᵀᴹ in Metastatic Urothelial Cancer September 19, 2020Trodelvyᵀᴹ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer September 18, 2020Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers September 9, 2020Immunomedics Announces Key Oral Presentations at ESMO 2020 September 2, 2020Immunomedics to Participate in Upcoming Healthcare Conferences August 17, 2020Immunomedics Announces FDA Approval of Samsung Biologics as Antibody Manufacturer of Trodelvyᵀᴹ August 5, 2020Immunomedics Announces Second Quarter 2020 Results and Provides Corporate Update July 27, 2020Immunomedics to Report Second Quarter 2020 Results and Host Conference Call and Webcast on August 5, 2020 Pagination First page << Previous page < Page 1 / 4 Next page > Last page >>
